208 related articles for article (PubMed ID: 18098272)
1. Cost-effectiveness of targeted and tailored interventions on colorectal cancer screening use.
Lairson DR; DiCarlo M; Myers RE; Wolf T; Cocroft J; Sifri R; Rosenthal M; Vernon SW; Wender R
Cancer; 2008 Feb; 112(4):779-88. PubMed ID: 18098272
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled trial of the impact of targeted and tailored interventions on colorectal cancer screening.
Myers RE; Sifri R; Hyslop T; Rosenthal M; Vernon SW; Cocroft J; Wolf T; Andrel J; Wender R
Cancer; 2007 Nov; 110(9):2083-91. PubMed ID: 17893869
[TBL] [Abstract][Full Text] [Related]
3. Costs and cost-effectiveness of a low-intensity patient-directed intervention to promote colorectal cancer screening.
Shankaran V; McKoy JM; Dandade N; Nonzee N; Tigue CA; Bennett CL; Denberg TD
J Clin Oncol; 2007 Nov; 25(33):5248-53. PubMed ID: 18024871
[TBL] [Abstract][Full Text] [Related]
4. Costs and cost effectiveness of a health care provider-directed intervention to promote colorectal cancer screening among Veterans.
Wolf MS; Fitzner KA; Powell EF; McCaffrey KR; Pickard AS; McKoy JM; Lindenberg J; Schumock GT; Carson KR; Ferreira MR; Dolan NC; Bennett CL
J Clin Oncol; 2005 Dec; 23(34):8877-83. PubMed ID: 16314648
[TBL] [Abstract][Full Text] [Related]
5. A cost-effectiveness comparison of three tailored interventions to increase mammography screening.
Saywell RM; Champion VL; Skinner CS; Menon U; Daggy J
J Womens Health (Larchmt); 2004 Oct; 13(8):909-18. PubMed ID: 15671706
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of tailored print materials in promoting colorectal cancer screening: results from a randomized trial involving callers to the National Cancer Institute's Cancer Information Service.
Marcus AC; Mason M; Wolfe P; Rimer BK; Lipkus I; Strecher V; Warneke R; Morra ME; Allen AR; Davis SW; Gaier A; Graves C; Julesberg K; Nguyen L; Perocchia R; Speyer JB; Wagner D; Thomsen C; Bright MA
J Health Commun; 2005; 10 Suppl 1():83-104. PubMed ID: 16377602
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of a tailored intervention to increase screening in HMO women overdue for Pap test and mammography services.
Lynch FL; Whitlock EP; Valanis BG; Smith SK
Prev Med; 2004 Apr; 38(4):403-11. PubMed ID: 15020173
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness analysis of two strategies for mass screening for colorectal cancer in France.
Berchi C; Bouvier V; Réaud JM; Launoy G
Health Econ; 2004 Mar; 13(3):227-38. PubMed ID: 14981648
[TBL] [Abstract][Full Text] [Related]
9. The safety net: a cost-effective approach to improving breast and cervical cancer screening.
Vogt TM; Glass A; Glasgow RE; La Chance PA; Lichtenstein E
J Womens Health (Larchmt); 2003 Oct; 12(8):789-98. PubMed ID: 14588129
[TBL] [Abstract][Full Text] [Related]
10. Tailored navigation in colorectal cancer screening.
Myers RE; Hyslop T; Sifri R; Bittner-Fagan H; Katurakes NC; Cocroft J; Dicarlo M; Wolf T
Med Care; 2008 Sep; 46(9 Suppl 1):S123-31. PubMed ID: 18725824
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness comparison of five interventions to increase mammography screening.
Saywell RM; Champion VL; Skinner CS; McQuillen D; Martin D; Maraj M
Prev Med; 1999 Nov; 29(5):374-82. PubMed ID: 10564629
[TBL] [Abstract][Full Text] [Related]
12. Using tailored telephone counseling to accelerate the adoption of colorectal cancer screening.
Costanza ME; Luckmann R; Stoddard AM; White MJ; Stark JR; Avrunin JS; Rosal MC; Clemow L
Cancer Detect Prev; 2007; 31(3):191-8. PubMed ID: 17646058
[TBL] [Abstract][Full Text] [Related]
13. The Next Step Trial: impact of a worksite colorectal cancer screening promotion program.
Tilley BC; Vernon SW; Myers R; Glanz K; Lu M; Hirst K; Kristal AR
Prev Med; 1999 Mar; 28(3):276-83. PubMed ID: 10072746
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of capsule endoscopy in screening for colorectal cancer.
Hassan C; Zullo A; Winn S; Morini S
Endoscopy; 2008 May; 40(5):414-21. PubMed ID: 18302080
[TBL] [Abstract][Full Text] [Related]
15. High participation rates are not necessary for cost-effective colorectal cancer screening.
Howard K; Salkeld G; Irwig L; Adelstein BA
J Med Screen; 2005; 12(2):96-102. PubMed ID: 15949121
[TBL] [Abstract][Full Text] [Related]
16. The role of family physicians in increasing annual fecal occult blood test screening coverage: a prospective intervention study.
Vinker S; Nakar S; Rosenberg E; Kitai E
Isr Med Assoc J; 2002 Jun; 4(6):424-5. PubMed ID: 12073414
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16).
Chen LS; Liao CS; Chang SH; Lai HC; Chen TH
J Med Screen; 2007; 14(4):191-9. PubMed ID: 18078564
[TBL] [Abstract][Full Text] [Related]
18. Cost effectiveness of work-site cholesterol screening and intervention programs.
Wilson MG; Edmunson J; DeJoy DM
J Occup Med; 1992 Jun; 34(6):642-9. PubMed ID: 1619496
[TBL] [Abstract][Full Text] [Related]
19. Failure of automated telephone outreach with speech recognition to improve colorectal cancer screening: a randomized controlled trial.
Simon SR; Zhang F; Soumerai SB; Ensroth A; Bernstein L; Fletcher RH; Ross-Degnan D
Arch Intern Med; 2010 Feb; 170(3):264-70. PubMed ID: 20142572
[TBL] [Abstract][Full Text] [Related]
20. Effects of a tailored interactive multimedia computer program on determinants of colorectal cancer screening: a randomized controlled pilot study in physician offices.
Jerant A; Kravitz RL; Rooney M; Amerson S; Kreuter M; Franks P
Patient Educ Couns; 2007 Apr; 66(1):67-74. PubMed ID: 17156968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
